FDA approves Adempas to treat pulmonary hypertension
The U.S. Food and Drug Administration today approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension.
-
Subscribe
Subscribe via the RSS feed
The U.S. Food and Drug Administration today approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension.